购物车
全部删除
您的购物车当前为空
SARS-CoV-2-IN-112 (Compound 6f) 是一种口服活性非肽类SARS-CoV-2 main protease抑制剂,IC50为6.48 μM。它显示出显著的抗病毒效力,并对WI-38细胞表现出低细胞毒性 (IC50:53.81 μM)。SARS-CoV-2-IN-112 可用于冠状病毒COVID-19的研究。
SARS-CoV-2-IN-112 (Compound 6f) 是一种口服活性非肽类SARS-CoV-2 main protease抑制剂,IC50为6.48 μM。它显示出显著的抗病毒效力,并对WI-38细胞表现出低细胞毒性 (IC50:53.81 μM)。SARS-CoV-2-IN-112 可用于冠状病毒COVID-19的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
SARS-CoV-2-IN-112 相关产品
| 产品描述 | SARS-CoV-2-IN-112 (Compound 6f) is an orally active, non-peptidic inhibitor of the SARS-CoV-2 main protease with an IC50 of 6.48 μM. It exhibits potent antiviral activity while demonstrating low cytotoxicity against WI-38 cells (IC50: 53.81 μM). SARS-CoV-2-IN-112 is applicable for coronavirus COVID-19 research. |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容